High-Impact Form 4 Intelligence
Real-time SEC insider trading data with advanced filtering. Free beta.
Total Buys (Filtered)
$0
$0
Total Sells (Filtered)
$716K
$716,000
| Ticker | Company | Reporting Owner | Date | Value (USD) | Type | Form 4 |
|---|---|---|---|---|---|---|
| CRNX |
Crinetics Pharmaceuticals, Inc.
|
Director
Other
|
2025-09-26 | $19,100 | M | Form 4 |
|
CRNX
S
Crinetics Pharmaceuticals, Inc.
Fust Matthew K
• Director
10b5-1 SellΔOwn -41.2%
2025-09-26
$716,000
|
||||||
| CRNX |
Crinetics Pharmaceuticals, Inc.
|
Director
10b5-1 SellΔOwn -41.2%
|
2025-09-26 | $716,000 | S | Form 4 |